PHI with Bowel cancer

Read in German: PKV mit Darmkrebs

How does this condition affect your private health insurance?

Colorectal cancer (Darmkrebs) originates in the large intestine, typically developing from precancerous polyps over many years. Symptoms often include changes in bowel habits, rectal bleeding, abdominal pain, and unexplained weight loss, though early stages might be asymptomatic. Screening colonoscopies are crucial for early detection and prevention. Treatment usually involves surgical removal of the tumor, often combined with chemotherapy, radiation therapy, or targeted biological therapies, depending on the cancer's stage and spread. Lifestyle factors, such as diet and physical activity, along with genetic predisposition, significantly influence risk. Prognosis is highly dependent on the stage at diagnosis, emphasizing the importance of timely medical intervention.

PKV Risk Assessment

Very High Risk of Rejection

Individual, specialized PHI providers may still insure you, but with a significant surcharge.

Impact on Your Insurance Policy

Duration of Illness (Initial)

Several weeks to a few months for diagnosis and initial treatment phase

Duration of Illness (Lifetime)

Potentially a one-time event if cured early; chronic with ongoing surveillance, potential recurrence, or long-term management for advanced stages, lasting years or a lifetime

Cost of Treatment (Initial)

30,000 - 100,000+ EUR/USD, depending on stage and healthcare system

Cost of Treatment (Lifetime)

100,000 - 500,000+ EUR/USD, especially if chronic, recurring, or requiring extensive follow-up and palliative care

Mortality Rate

Moderate to high (approx. 30-40% overall 5-year mortality, but highly variable by stage; >90% 5-year survival in Stage I, <15% in Stage IV)

Risk of Secondary Damages

High (e.g., permanent ostomy, bowel dysfunction, nerve damage, chemotherapy-induced neuropathy, fatigue, psychological distress, lymphedema)

Probability of Full Recovery

Moderate to high in early stages (>90% for Stage I), significantly lower in advanced stages (<15% for Stage IV)

Underlying Disease Risk

Moderate (e.g., inflammatory bowel diseases like Crohn's or ulcerative colitis, familial adenomatous polyposis, Lynch syndrome, obesity, type 2 diabetes)

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.